Liver Transplant for Upfront Unresectable Colorectal Metastases
- PMID: 40833684
- PMCID: PMC12368790
- DOI: 10.1001/jamasurg.2025.2879
Liver Transplant for Upfront Unresectable Colorectal Metastases
Plain language summary
This cohort study evaluates outcomes following liver transplant among patients with colorectal liver metastases.
Conflict of interest statement
References
-
- Adam R, Piedvache C, Chiche L, et al. ; Collaborative TransMet group . Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. Lancet. 2024;404(10458):1107-1118. doi: 10.1016/S0140-6736(24)01595-2 - DOI - PubMed
-
- Chávez-Villa M, Sasaki K, Nakayama T, et al. The urgent need for standardization in liver transplantation for unresectable colorectal liver metastases in the United States. Am J Transplant. 2025;25(1):S108. doi: 10.1016/j.ajt.2024.12.214 - DOI
LinkOut - more resources
Full Text Sources